Shares of Insulet Corporation (PODD) slipped ~7% on Thursday as the insulin pump maker announced its long-term financial outlook during its 2025 Investor Day at the company’s headquarters in Acton, ...
Hosted on MSN
UBS Upgrades Insulet (PODD)
Fintel reports that on November 19, 2025, UBS upgraded their outlook for Insulet (NasdaqGS:PODD) from Neutral to Buy. Analyst Price Forecast Suggests 9.42% Upside As of November 17, 2025, the average ...
Shares of Insulet Corporation (PODD) traded higher on Wednesday after UBS upgraded the insulin pump maker to Buy from Neutral just ahead of its Investor Day on Nov. 20, citing the company’s growth ...
(Photo by Kirk Mckoy/Los Angeles Times via Getty Images) When it comes to surgical innovation, Intuitive Surgical (NASDAQ: ISRG) often dominates investor attention. But Insulet Corporation (NASDAQ: ...
Below is Validea's guru fundamental report for INSULET CORP (PODD). Of the 22 guru strategies we follow, PODD rates highest using our Twin Momentum Investor model based on the published strategy of ...
Sales are surging for Insulet Corporation (PODD). Insulet develops, manufactures, and markets the Omnipod Insulin Management System for those with Type 2 diabetes. The system is worn on the body for ...
If you purchase an independently reviewed product or service through a link on our website, Rolling Stone may receive an affiliate commission. 30-day free trial at walmart Plus Like Prime, Walmart ...
Streaming engineer and strategist and Streaming Media The Video Doctor columnist Robert Reinhardt of VideoRx discusses some of his favorite features of the new AJA HELO Plus Advanced Streaming and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback